Cilibrasi, C.; Simon, T.; Vintu, M.; Tolias, C.; Samuels, M.; Mazarakis, N.K.; Eravci, M.; Stewart, N.; Critchley, G.; Giamas, G.
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients. Biomedicines 2022, 10, 125.
https://doi.org/10.3390/biomedicines10010125
AMA Style
Cilibrasi C, Simon T, Vintu M, Tolias C, Samuels M, Mazarakis NK, Eravci M, Stewart N, Critchley G, Giamas G.
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients. Biomedicines. 2022; 10(1):125.
https://doi.org/10.3390/biomedicines10010125
Chicago/Turabian Style
Cilibrasi, Chiara, Thomas Simon, Marian Vintu, Christos Tolias, Mark Samuels, Nektarios K. Mazarakis, Murat Eravci, Nicolas Stewart, Giles Critchley, and Georgios Giamas.
2022. "Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients" Biomedicines 10, no. 1: 125.
https://doi.org/10.3390/biomedicines10010125
APA Style
Cilibrasi, C., Simon, T., Vintu, M., Tolias, C., Samuels, M., Mazarakis, N. K., Eravci, M., Stewart, N., Critchley, G., & Giamas, G.
(2022). Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients. Biomedicines, 10(1), 125.
https://doi.org/10.3390/biomedicines10010125